Your browser doesn't support javascript.
loading
Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common CDKN2A Alteration.
Elvin, Julia A; Gay, Laurie M; Ort, Rita; Shuluk, Joseph; Long, Jennifer; Shelley, Lauren; Lee, Ronald; Chalmers, Zachary R; Frampton, Garrett M; Ali, Siraj M; Schrock, Alexa B; Miller, Vincent A; Stephens, Philip J; Ross, Jeffrey S; Frank, Richard.
Afiliação
  • Elvin JA; Pathology Department, Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Gay LM; Pathology Department, Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Ort R; Hematology and Oncology, Norwalk Hospital, Western Connecticut Health Network, Norwalk, Connecticut, USA.
  • Shuluk J; Hematology and Oncology, Norwalk Hospital, Western Connecticut Health Network, Norwalk, Connecticut, USA.
  • Long J; Hematology and Oncology, Norwalk Hospital, Western Connecticut Health Network, Norwalk, Connecticut, USA.
  • Shelley L; Hematology and Oncology, Norwalk Hospital, Western Connecticut Health Network, Norwalk, Connecticut, USA.
  • Lee R; Radiology, Norwalk Hospital, Western Connecticut Health Network, Norwalk, Connecticut, USA.
  • Chalmers ZR; Clinical Genomics, Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
  • Frampton GM; Clinical Genomics, Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
  • Ali SM; Clinical Development, Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
  • Schrock AB; Clinical Development, Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
  • Miller VA; Clinical Development, Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
  • Stephens PJ; Clinical Genomics, Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
  • Ross JS; Pathology Department, Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Frank R; Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany.
Oncologist ; 22(4): 416-421, 2017 04.
Article em En | MEDLINE | ID: mdl-28283584

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Piridinas / Neoplasias Uterinas / Inibidor de Quinase Dependente de Ciclina p18 / Leiomiossarcoma Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Piridinas / Neoplasias Uterinas / Inibidor de Quinase Dependente de Ciclina p18 / Leiomiossarcoma Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos